Updates in Frontline Therapy for Lymphoma: Perspectives on the POLARIX and SWOG S1826 Clinical Trials

home / pivotal-practice-views-with-the-oncology-brothers / updates-in-1l-therapy-for-lymphoma-perspectives-on-polarix-and-s1826-clinical-trials

Oncology Brothers Rohit Gosain, MD, and Rahul Gosain, MD, are joined by expert Jonathan Friedberg, MD, MMSc, in their review of respective data from POLARIX in DLBCL and SWOG S1826 in Hodgkin’s Lymphoma.